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Abstract
The direct detection of ancient Mycobacterium tuberculosis molecular biomarkers has profoundly changed our understanding of the dis-
ease in ancient and historical times. Initially, diagnosis was based on visual changes to skeletal human remains, supplemented by radiolog-
ical examination. The introduction of biomolecular methods has enabled the speciﬁc identiﬁcation of tuberculosis in human tissues, and
has expanded our knowledge of the palaeopathological changes associated with the disease. We now realize that the incidence of past
tuberculosis was greater than previously estimated, as M. tuberculosis biomarkers can be found in calciﬁed and non-calciﬁed tissues with
non-speciﬁc or no visible pathological changes. Modern concepts of the origin and evolution of M. tuberculosis are informed by the
detection of lineages of known location and date.
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Early Morphological Studies
You have to know the past to understand the present Dr
Carl Sagan (1934–1996)
Tuberculosis (TB) is a disease that was recognized in ancient
times, primarily by the characteristic changes to the spine
(kyphosis or gibbus) that result in Pott’s disease. The emi-
nent Greek physician Hippocrates (460–370 BC) gives a
clear description of kyphosis, stating that it can be the result
of disease, can occur above or below the diaphragm, and is
associated with hard tubercles in the lungs, and abscesses in
the lumbar region [1]. He also noted that patients had a
poor prognosis if the spinal curvature was above the dia-
phragm and if the patient was a child or young adult. Many
other ancient and historical texts contain recognizable
descriptions of TB, where the disease is identiﬁed as phthisis,
scrofula, King’s Evil, lupus vulgaris, consumption, etc. [2]. As
palaeopathology emerged from physical anthropology and
forensic science as a distinct discipline, diagnostic criteria
based on skeletal changes were agreed [3,4].
As part of an ongoing process, detailed morphological
studies were performed on more recent historical skeletal
collections with contemporaneous records of the individual
cases, including age, sex, occupation, symptoms, and cause of
death [5–7]. This led to the realization that some bony
changes, such as periostitis (surface changes caused by new
bone formation) on ribs, were signiﬁcantly associated with
individuals who had been diagnosed as having clinical TB.
Other conditions linked to recognized TB changes include
hypertrophic osteoarthropathy (HOA) [8,9] and serpens
endocrania symmetrica—a morphological sign of respiratory
distress and increased vascularization around the brain [8].
The use of palaeohistology [10] also aids the recognition
of more subtle changes associated with TB in calciﬁed and
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non-calciﬁed tissues. Mummiﬁed remains can demonstrate
signs of TB, such as granulomas in lung and other organs.
Indeed, Allison et al. [11] used histological methods to rehy-
drate such tissue from a pre-Columbian Andean mummy
(AD 200–800), and demonstrated bacteria within granulomas
that were acid-fast by the Ziehl–Neelson stain, with the typi-
cal microscopic appearance of mycobacteria. Radiological
imaging gives additional data, and the use of computerized
tomography facilitates the three-dimensional examination of
morphological features. Micro-computerized tomography is
becoming used more frequently, although there are concerns
about the increased radiation load, which may impact on the
recovery of biomolecular markers such as ancient DNA
(aDNA) (see below).
Early studies, based on visual appearance, radiology, and a
limited number of microscopic and histological investigations,
led to the conclusion that TB deﬁnitely occurred in ancient
populations but that it was comparatively rare. The earliest
cases recognized were from Neolithic times [12,13], so the
hypothesis that TB was associated with animal domestication
and that human TB originated from Mycobacterium bovis [3]
became widely accepted. The signiﬁcance of the ﬁnding of
acid-fast bacilli within granulomas in pre-Columbian mummi-
ﬁed tissue [11] was not generally appreciated, and several
subsequent publications included the suggestion that Colum-
bus and subsequent European contacts introduced TB to the
Americas.
Early Biomolecular Studies
The use of cloning to detect DNA from the extinct quagga
in 1984 [14] opened up the prospect of direct genetic stud-
ies of archaeological material. However, this only became
practicable after the development of PCR [15], which enables
rapid ampliﬁcation of speciﬁc genetic loci deﬁned by oligo-
nucleotide primers. There was an explosion of studies based
on extinct animals, plants, and other remains, several of
which are now suspect, owing to the lack of appropriate
measures to prevent contamination with modern DNA. The
early development of this ﬁeld in archaeology and palaeontol-
ogy had a strong inﬂuence on the initial criteria that emerged
regarding the precautions required for the production of
veriﬁable data based on aDNA [16,17]. These have since
been modiﬁed [18] to take account of our increased under-
standing of the sources of contamination [19] and the stabil-
ity of Mycobacterium tuberculosis complex (MTBC) aDNA
[20] as compared with other biomolecules [21,22].
TB was the ﬁrst infectious disease to be successfully
detected by PCR in bones [23] and mummiﬁed tissue [24],
owing to a fortuitous combination of circumstances. There
were agreed morphological diagnostic criteria, appropriate
DNA extraction procedures had been developed, and clini-
cal microbiologists had designed speciﬁc PCR primers. The
driving force for molecular diagnosis of TB was the extre-
mely slow growth rate of the causative organism, M. tuber-
culosis, and the other closely related members of the
MTBC. Clinical treatment is the same for all members of
the MTBC, so no attempt was made at the time to distin-
guish between its members. The ﬁrst primers used were
based on an MTBC-speciﬁc locus in the insertion sequence
IS6110, and, because it is usually present in multiple copies
within the bacterial cell, it was the preferred locus for
detection of tubercle bacilli. These early studies conﬁrmed
TB in Byzantine Turkey, pre-European contact Borneo, and
a pre-Columbian Andean mummy (1000 BP). They were
quickly followed by reports of MTBC aDNA in ancient
Egypt, China, America, and Europe, summarized in a series
of reviews [18,25–29].
It soon became apparent that MTBC aDNA could be
detected in material with non-speciﬁc pathology, such as ribs
with periostitis [30] and calciﬁed pleura [31]. Speciﬁc MTBC
mycolic acids, found in the bacterial cell wall, can provide
independent conﬁrmation of TB [31,32], which is of particu-
lar signiﬁcance, as the method is based on HPLC and there
is no ampliﬁcation of the target molecules. Recently, another
category of cell wall lipid biomarkers, the phthiocerol dimy-
cocerosate waxes, have enabled the detection of MTBC in
archaeological material by the use of negative ion chemical
ionization gas chromatography mass spectrometry of their
diagnostic mycocerosic acid components. Redman et al. [33]
investigated a group of 49 individuals from the 1837–1936
Coimbra Identiﬁed Skeletal Collection (Portugal), half of
whom had records giving TB as a cause of death. There was
a 72% correlation between detection of mycocerosate acid
biomarkers with individuals who were listed as likely to have
died from TB.
Re-evaluation of TB Palaeopathology as
Elucidated by Biomolecular Techniques
It had been observed by Baron et al. [34] that bone samples
from sites with obvious pathology, and from the same bone
but of apparently normal appearance, were positive for
MTBC aDNA. Their specimens were from a historical collec-
tion of individuals given a diagnosis of TB at autopsy,
and they concluded that the tubercle bacilli had been carried
into the bone with the bloodstream. They speculated further
that this raised the possibility that other infectious agents
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retrievable in blood should be detectable by PCR in the absence
of lesions—a supposition now known to be correct [28].
A small study of skeletal remains from 15–17th-century
Lithuania may have been the ﬁrst to deliberately include
bones from individuals with no bone pathology. Faerman
et al. [35] examined pathological lesions vs. healthy tissue
from the same skeleton, using four individuals. Three addi-
tional skeletal remains, chosen at random from the same
site, were also examined, plus soil samples to test the speci-
ﬁcity of the PCR primers. Compact bone and teeth were
examined. All seven individuals contained MTBC aDNA. One
soil sample was also positive, but further analysis showed
that only a sub-specimen containing small pieces of skin and
cartilage was positive. The authors concluded that they had
obtained direct evidence for haematogenous spread of tuber-
cle bacilli. They observed that many clinical forms of TB
leave no speciﬁc traces on the skeleton, and suggested that
the disease may be detectable even in individuals represented
by only a single bone or tooth.
Zink et al. [30] examined the relationship between mor-
phological bony changes and TB in ancient Egypt. They
examined 41 bones: 37 from the necropolis of Thebes-
West (2120–500 BC), and four from the necropolis of Aby-
dos (3000 BC). Only three subjects had pathological
changes typical of TB, whereas 17 showed pathological
changes that were non-speciﬁc but were likely to have been
caused by TB. The remaining 20 specimens were viewed as
controls, and had no visible pathology. Of 30 specimens
that contained human DNA, nine were positive for MTBC
DNA: two of the three with typical pathology, ﬁve of 13
with non-speciﬁc pathology but that were probable cases of
TB (including two from 3000 BC), and two of 14 with no
pathological changes.
Mays et al. [36] noted that tuberculous lesions in the ribs
arise by extension from spinal lesions, from haematogenous
spread from some remote soft tissue focus, or by direct
spread from disease in the lungs, pleura, or chest wall lym-
phatic system. In the clinical literature, lytic lesions, caused
by dissemination of disease from remote soft tissue foci via
the bloodstream, are believed to be the most frequent form
of rib involvement in TB, and in such cases bony changes
would not be expected. Mays et al. examined 14 ribs from a
deserted mediaeval village in north-eastern England (10–16th
century AD), seven with pathological surface pathology, and
seven forming an age-matched and sex-matched control
group, but with no visual or radiological sign of pathology.
MTBC aDNA was detected in one rib with pathology and in
two control ribs, indicating that the absence of visible pathol-
ogy does not preclude detection of tuberculous biomarkers.
The failure to detect MTBC aDNA in bones with pathology
is most likely attributable to poor DNA preservation and/or
localized distribution within the bone.
A further example of the detection of TB in the absence
of visible markers is given by a study of skin tissues from 12
pre-Columbian (AD 140–1240) Andean mummies, where
Konomi et al. [37] demonstrated MTBC DNA in two individ-
uals. In addition, the study by Redman et al. [33] reported
that there were no visible signs of TB in 11 of the 49 skele-
tons that were positive for mycocerosates. Therefore, both
MTBC aDNA and cell wall lipid biomarkers have demon-
strated molecular traces of TB in the absence of speciﬁc pal-
aeopathology.
When MTBC aDNA was detected in bones from individu-
als with no obvious palaeopathology at all [30,35,36], this ini-
tially attracted criticism and the assumption of laboratory
contamination, until anthropologists became aware of the
low proportion of skeletal TB in clinical infections from the
recent pre-antibiotic era. It is estimated that bone TB occurs
in only 3–5% of infections [38], and that the spine is involved
in approximately 40% of these. Therefore, the earlier views
of the incidence of TB based solely on bone morphology
were necessarily severe underestimates. The detailed studies
on the relationship of rib lesions with TB [5–7] had indicated
that this might be the case, but until the use of speciﬁc
aDNA and lipid biomarkers, this could not be proved
(Table 1).
Identiﬁcation of Strains and Lineages
The development of molecular diagnostics and the increased
understanding of the MTBC genome encouraged efforts to
identify individual members of the MTBC in ancient material
and to distinguish between strains and lineages. Methods are
based mainly on copy number of repetitive sequences, dele-
tion analysis, and single-nucleotide polymorphisms (SNPs).
Sreevatsan et al. [39] described three SNP types based on
katG463 CTG to CGG and subsequent gyrA95 ACC to AGC
mutations, thereby proposing an evolutionary pathway for
the tubercle bacilli.
TABLE 1. Objectives of studying tuberculosis (TB) palae-
omicrobiology
Conﬁrmation of palaeopathological changes associated with TB
Gain a better understanding of the majority of past TB infections that
leave no visible signs of disease
To examine ancient TB in relation to diet, health, and social structures
Geographical range in the past in relation to human and pathogen lineages
Comparison of microbial pathogens from the past with those of today
Provision of real-time markers of genetic changes
Enable monitoring of changes in virulence over a longer time-scale
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Spoligotyping is based on the direct repeat (DR) region of
the MTBC [40]. PCR primers in the DR region amplify up to
43 unique spacer regions that lie between each DR locus.
The spacers are visualized by dot blot hybridization on a
membrane, giving a ﬁngerprint, and patterns are stored on
an international database. Thus, Taylor et al. [41] were able
to demonstrate, using spoligotyping and SNPs, that bones
from mediaeval London (AD 1350–1538) were infected with
M. tuberculosis rather than M. bovis. Both human and cattle
bones with periostitis from an earlier mediaeval site in
northern England were examined for M. tuberculosis and
M. bovis [42], but only M. tuberculosis was detected, and only
in human remains. Indeed, to date, there is only one site
where human archaeological cases of M. bovis have been
identiﬁed, and this concerns Iron Age pastoralists (360 BC
to AD 230) from southern Siberia [43,44].
Animal bones have proved a difﬁcult subject for the study
of past TB. There is one report of an Iroquoian dog from
the 16th century, with the TB-associated but non-speciﬁc
palaeopathological condition HOA [45], in which MTBC
aDNA was found. A histological study of the HOA patholog-
ical lesions in these remains [46] indicated that the dog had
experienced a long and most likely arduous period of illness.
The animal was buried with purpose and lived within a long-
house environment [45], thus providing the perfect opportu-
nity for the transmission of an interspecies (and intraspecies)
TB infection.
However, the rarity of animals in the pathological record
can no doubt be explained by the fact that most collections
of animal bones are from domesticated animals used for
food. These rarely live a sufﬁcient time to develop recogniz-
able lesions or to die a natural death. Once the animals are
killed, the carcases will be butchered, cooked, and eaten.
Bones will be used if possible, or discarded. An exception to
this scenario was discovered in the Natural Trap Cave in
Wyoming, USA. This cave is 30 m deep and presents an
unavoidable hazard on a game trail, thereby providing an
unbiased sample over >100 000 years of the many passing
species. Owing to the depth of the cave, falls are invariably
fatal, and the temperature remains constant at 4–5C, which
is known to be conducive for aDNA persistence. Palaeo-
pathological changes were occasionally noted in bovids, and
a metatarsal from an extinct long-horned bison
(17 870 ± 230 BP) was found to contain MTBC aDNA [47].
Further characterization was attempted, and consensus spoli-
gotyping indicated an ancestral version of the MTBC DR
region, rather than the typing patterns associated with
M. bovis or most extant strains of M. tuberculosis.
The ﬁrst indication of human TB infections caused by
another member of the MTBC was in a population study
from Thebes West in ancient Egypt [48]. Spoligotyping indi-
cated that M. tuberculosis was present in most of the infected
individuals, but there appeared to be one case where Myco-
bacterium africanum was implicated. A follow-up study of
bone and soft tissue samples from 118 individuals compared
the incidence of TB over three time periods. This revealed
several samples with an M. africanum spoligotype pattern
from a Middle Kingdom tomb (2050–1650 BC), whereas
samples from later periods were all typical of M. tuberculosis
[49]. There was no indication of M. bovis. The authors con-
cluded that these ﬁndings did not support the theory that
M. tuberculosis had evolved from M. bovis.
Palaeoepidemiology of TB
To estimate disease prevalence over a long time-span, the
occurrence of TB in vertebral bones only was examined at
Thebes-West in Ancient Egypt. Specimens were from three
time periods: the pre-dynastic to early dynastic period
(c. 3500–2650 BC), the Middle Kingdom to the Second Inter-
mediate Period (c. 2100–1550 BC), and the New Kingdom
to the Late Period (c. 1450–500 BC) [50]. MTBC aDNA was
found in 18 of the 50 individuals with detectable human
aDNA throughout these time periods, indicating the long-
term association of host and bacterial pathogen. There were
more positives in individuals with typical TB pathology, but
seven of 50 positive cases had bones of normal appearance.
A population study on a more recent, but exceptionally
well-preserved, collection of naturally mummiﬁed or partially
mummiﬁed remains was based on a collection of 263 individu-
als buried during the 18th century, in a church crypt that was
sealed and only rediscovered in the early 1990s [51,52]. Con-
temporaneous civic and church records were available, so it
was possible to determine TB prevalence according to age,
sex, occupation, and family group. TB was assessed initially by
visual and radiographic evidence of palaeopathology and con-
temporary records. Independent research groups determined
the presence of MTBC aDNA, and found over 60% of individ-
uals to be infected [18]. Molecular typing showed that three
members of a family group were infected with separate strains
of M. tuberculosis. A mother was infected with a different SNP
genotype [39] from her two daughters [52], thus suggesting
that, in this high-incidence population, infection was acquired
from the community, not within the family.
An intriguing aspect of palaeomicrobiology is the ability
to detect co-infections by the use of speciﬁc biomarkers.
Donoghue et al. [53] detected both MTBC and Mycobacterium
leprae aDNA in skeletal material from individuals with obvious
palaeopathology for lepromatous leprosy. This had been
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prompted by reports in the clinical literature of leprosy
patients dying of TB, as M. tuberculosis is the more virulent
pathogen in such patients. Other past populations with molec-
ular evidence of two or more infectious diseases include the
Early Christian Nubian population of Kulubnarti, where both
TB and leishmaniasis were identiﬁed, and 15–16th-century
‘wet’ Korean mummies, in which many intestinal parasites, TB
and hepatitis B virus have been detected [18].
Setting the Molecular Clock—direct
Determination of Past MTBC Lineages
Brosch et al. [54] demonstrated that the SNP types identiﬁed
by Sreevatsan et al. [39] occurred in a lineage of M. tuberculo-
sis strains that had already lost M. tuberculosis speciﬁc dele-
tion 1 (TbD1) (Fig. 1), and redeﬁned them as markers of
three principal genetic groups (PGGs). The results of
Fletcher et al. [51] therefore demonstrated that M. tuberculo-
sis aDNA ampliﬁed from naturally mummiﬁed Hungarians
from the 18th and 19th centuries belonged to katG463/gyrA95
PGG2 and PGG3, and that the TbD1 deletion occurred in
the lineage of M. tuberculosis before the 18th century. At the
time of publication this was of interest, as it suggested that
the dramatic increase in the number of TB cases later in the
18th century in Europe involved the TbD1-deleted M. tuber-
culosis strains that are now prevalent in the developed world.
It also provided a further demonstration that TB was caused
by M. tuberculosis and not by M. bovis.
The time-scale for the emergence of distinct human lin-
eages was dramatically extended by the ﬁndings of Hershko-
vitz et al. [55]. Studies on the pre-Pottery Neolithic site of
Atlit Yam in the eastern Mediterranean, dating from 9250 to
8150 BP, demonstrated that a woman and infant were
infected with M. tuberculosis, based on morphological changes
to bones, the detection of MTBC-speciﬁc cell wall lipid bio-
markers, and the detection of aDNA. Bones were well pre-
served, as the skeletal remains had been buried in thick clay
under the sea, and DNA preservation was also good, so
some molecular characterization was possible. Several differ-
ent target loci were detected, including that of the TbD1
region. This demonstrated that these two individuals were
infected with M. tuberculosis from a TbD1-deleted lineage.
Phylogenomics of MTBC Strains
The individual members of the MTBC (excluding the strains
with smooth colonies classiﬁed as Mycobacterium canettii) are
99.95% identical on the basis of nucleotide sequence. This
gave rise to the suggestion that there had been an evolution-
ary bottleneck at the time of speciation [39], estimated by
ancestral sequence inference to have occurred 15 000–
20 000 years ago. However, there are clear differences in
phenotype, host tropism, and pathogenicity, so comparative
genomic studies were undertaken. Brosch et al. [54] analysed
20 variable regions situated around the genome of a repre-
sentative and diverse set of 100 MTBC strains, obtained
from different hosts and with a broad range of geographical
origins. The major ﬁnding was that MTBC strains have
undergone reductive evolution by the unidirectional loss of
chromosomal sequences. Once a non-repetitive region has
been deleted, it cannot be replaced, and the deletion is a
biomarker of a clone derived from a single cell and all of
its descendants [56]. The application of deletion analysis
thus demonstrates unambiguously that M. bovis has under-
gone numerous deletions relative to M. tuberculosis, and
M. tuberculosis is therefore a more ancestral lineage. The
FIG. 1.Working model of the evolu-
tionary scheme of tubercle bacilli [68],
which was based on earlier versions
[54,59]. There is a unidirectional succes-
sive loss of DNA, and the scheme is
based on the presence or absence of
conserved regions of difference (RDs)
(TbD1) and sequence polymorphisms in
ﬁve selected genes. The model is sche-
matic, and the distances between certain
branches do not necessarily correspond
to calculated phylogenetic differences.
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TbD1 locus is absent from the majority of strains now pre-
valent in Europe and the Americas, but occurs in strains of
different geographical origin and in MTBC lineages associated
with animal hosts. Therefore, Brosch et al. [54] and subse-
quent authors identiﬁed the TbD1 deletion as a marker of
importance in our understanding of the evolution of the
MTBC. This is supported by total genome sequencing of
M. tuberculosis [57] and M. bovis [58], which has shown that
the M. bovis genome is slightly smaller (98.5%) and has
undergone 11 deletions in comparison with M. tuberculosis.
In the search for the source of the MTBC, Gutierrrez et al.
[59] re-examined M. canettii, which Brosch et al. [54] had con-
cluded was a distinct outlier group with the most ancestral
characteristics. Indeed, it became clear that different strains of
M. canettii displayed more variation than is found in all the
other species or ecotypes [56] in the MTBC. This led the
authors to the hypothesis that the MTBC had emerged, via an
evolutionary bottleneck, from a postulated species with the
expected range of internal clonal variation, termed ‘Mycobac-
terium prototuberculosis’. Using synonymous sequence diver-
sity to estimate the minimal age of the last common ancestor,
they concluded that the bacteria responsible for tuberculosis
have co-evolved with early humans since at least the time of
early hominids, between 2.6 and 2.8 million years ago. There is
continuing debate about this suggested scenario, but, mean-
while, a possible case of TB in Homo erectus dated to (490–
510) ± 0.05 Ka (thousand years) was described in a partial
skeleton discovered in western Turkey [60]. The diagnosis
was based on endocranial palaeopathology distinct from
serpens endocrania symmetrica, termed leptomeningitis tubercul-
osa, believed to be associated with tuberculous meningitis, but
critics believe that this diagnosis is premature and based on
inadequate evidence [61]. This remains an intriguing possibility
that awaits the application of next-generation molecular meth-
ods for clariﬁcation.
Relationship of Tubercle Bacilli to Different
Human Societies
The use of standardized methods of reporting skeletal collec-
tions, and the study of past populations in the context of
their diet, living conditions, work patterns, and type of soci-
ety, has facilitated the study of health and disease over time
[62]. Evidence of habitations, population density, animal
domestication, tools and agriculture is supplied by traditional
archaeological assessments. Carbon and nitrogen stable iso-
tope analysis can give information on the type of diet eaten,
e.g. terrestrial, marine, freshwater, meat, or dairy. Coprolite
analysis can also provide data on nutrition and calorie intake,
based on identiﬁcation of bones, seeds, pollen, etc. in pre-
served faeces. Strontium and oxygen isotopes can give an
indication of location and mobility during a lifetime. There
may also be evidence of major climatic events, such as earth-
quakes and tsunamis changing sea levels, or the height of the
annual ﬂooding of the Nile [63].
TB is a disease that can exist as a latent infection through-
out the lifetime of a host, but that may be reactivated or re-
acquired when host resistance is impaired. In addition to the
extremes of life, individuals become susceptible to active dis-
ease when suffering from poor nutrition, other serious medi-
cal conditions, or severe mental or physical stress. Today, it
is estimated by the WHO that one-third of the global popu-
lation is infected with tubercle bacilli but that only 10% of
individuals will develop disease in their lifetime (Fig. 2). The
implication of the high proportion of latent infections is that
there has been a prolonged period of co-evolution of host
and pathogen. This is also indicated by the detection of a
TbD1-deleted lineage in the early Neolithic site at Atlit Yam.
Evolutionary biologists have postulated that, in the long
period of human evolution that pre-dated the Neolithic,
tubercle bacilli occupied an unusual ecological niche in human
biology. While populations were primarily small, mobile, and
often family groups, the organisms could survive only by sur-
viving throughout the lifetime of their host, with transmission
occurring from adults with reactivated disease resulting from
an age-related failing immune system, or from other severe
disease or stress. Infants are more susceptible to acquisition
of disease, and, because of their immature immune system,
may have a high mortality with primary disseminated TB,
thereby providing an opportunity for transmission soon after
infection. Therefore, tubercle bacilli adopt a quasi-commensal
relationship with their host in the majority of cases [64].
FIG. 2. The global burden of tuberculosis (TB) estimated by the
WHO. Each section of the pyramid drawn is roughly to scale, and
the bar to the right represents the spectrum of different lesion types
seen in latent infections [69]. PPD.
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This scenario explains the development of the clonal rela-
tionship of the MTBC complex members with their host,
where particular bacterial lineages are associated with human
lineages, even in the modern world and in second-generation
or third-generation inhabitants of ethnically diverse cities [65]
(Fig. 3). However, when the human population density rises
signiﬁcantly, there is a greater opportunity for transmission to
susceptible hosts, so bacterial virulence is likely to increase,
owing to natural selection. This has now been manifested by
the development of evolutionarily modern lineages of M. tuber-
culosis, which induce a lower level of early inﬂammatory
response in the host and demonstrate faster progression to
active disease [66]. Therefore, reﬂecting the co-evolution of
host and pathogen, it is unsurprising that length of urbanization
is a predictor of host genetic resistance to TB [67].
Concluding Remarks
At this time of rapid population growth and the emergence
of new virulent M. tuberculosis lineages, it is especially impor-
tant that we understand the history of TB and evolution of
the host–pathogen relationship. This chronological review
also allows us to follow the sequence of observations, emer-
gence of concepts and changes in our perception of this rela-
tionship (Table 2). Palaeomicrobiology offers a unique
opportunity to detect past lineages that may no longer be
extant. It also enables us to calibrate the molecular clock
when calculating time to most recent common ancestor by
ancestral sequence inference. By providing direct evidence of
speciﬁc biomolecular markers, palaeopathologists are able to
make better assessments of the past prevalence of disease
and to identify TB-associated skeletal changes with more
conﬁdence. In this regard, it is important to extend palaeo-
microbiological studies around the world to obtain as com-
prehensive a picture as possible. The development of next-
generation technology and additional biomarkers, with
greater stability than DNA, should enable us to explore even
further back into the past.
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Additional palaeopathological indicators of TB authenticated
Evidence of haematogenous and direct spread of tubercle bacilli within the body
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Appreciation that former estimates of TB infection were far too low
Conﬁrmation of geographical distribution in ancient times; for example,
TB existed in Borneo before European contact, existed in
pre-Columbian America, and was widespread in ancient Egypt and Rome
M. tuberculosis complex DNA detected in North American bison from the
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crossed the Bering land bridge
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Mycobacterium bovis only clearly identiﬁed in human remains from Iron Age
pastoralists in southern Siberia
Co-infections identiﬁed in some human remains
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